Document Type
Original Article
Abstract
Background: Single nucleotide polymorphisms (SNPs) of the IL-28B gene are reliable predictors of chronic HCV disease course after treatment with Peg-IFN and Ribavirin (RBV). Aims, Subjects and Methods: Impacts of IL-28B-SNPs on the response to direct acting antivirals (DAAs) were evaluated in posttreatment negative serum and cellular HCV-PCR (group I), solitary intra-PBMCs viral infections (group II), and positive HCV-RNA serology (group III). Twelve weeks after completing DAAs-therapy, 45 patients were recruited and divided into three groups (n=15each), as afro-mentioned. IL-28B gene sequencing was done to detect SNPs in relation to hepatic parenchymal changes in the selected study populations. Results and conclusion: Changes in liver parenchyma of group III (46.7%) and II (26.6%) were associated with higher HCV-relapse compared to I (P
Keywords
IL28B gene; PBMCs PCR; DAAs; HCV Relapse
How to Cite This Article
Abd Alla, Mohamed; altambouly, ahmed; Abd Alla, Mohamed; AbuFarrag, Galal; Ammar, Islam; and El-Awady, Mostafa
(2020)
"Evaluation of IL28B Gene Sequence Variations in the Diagnosed Null-Response to DAAs Therapy by Intra PBMCs Nested HCV RNA PCR,"
Al-Azhar International Medical Journal: Vol. 1:
Iss.
11, Article 11.
DOI: https://doi.org/10.21608/aimj.2021.40774.1313